-
Ultimovacs ASA: First quarter 2020 result presentation
-
Ultimovacs ASA: Invitation to first quarter 2020 result webcast presentation
-
Ultimovacs ASA – Annual General Meeting held on 23 April 2020
-
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
-
Ultimovacs ASA – Notice of Annual General Meeting on 23 April 2020
-
Ultimovacs ASA – Annual Report 2019
-
Ultimovacs ASA – Possible implications of the coronavirus (COVID-19) pandemic
-
Ultimovacs ASA: Fourth quarter 2019 result presentation
-
Ultimovacs ASA – Ultimovacs appoints Carlos de Sousa as new Chief Executive Officer
-
Ultimovacs ASA – Long term results from UV1 clinical study in patients with malignant melanoma
